NCT03345771

Brief Summary

The purpose of this study is to determine whether an occlusive antimicrobial barrier dressing or portable negative pressure wound dressing is superior in preventing wound complications and infection rates in obese patients undergoing total joint arthroplasty (TJA). Approximately 240 subjects (120 for total knee arthroplasty and 120 for total hip arthroplasty) will be enrolled to evaluate the outcomes associated with silver impregnated dressings and negative pressure wound therapy (NPWT) in treating this subset of patients and analyze the cost benefit of each.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
230

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Nov 2017

Typical duration for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 13, 2017

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

November 14, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 17, 2017

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2021

Completed
11 months until next milestone

Results Posted

Study results publicly available

April 22, 2022

Completed
Last Updated

April 22, 2022

Status Verified

March 1, 2022

Enrollment Period

3.4 years

First QC Date

November 14, 2017

Results QC Date

March 29, 2022

Last Update Submit

March 29, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Visual Analog Scale (VAS) Pain Score

    A patient is asked to indicate his/her perceived scar severity along a 100 mm horizontal line, and this rating is then measured from the left edge (=VAS score). The total score range is 0 (worst possible scar) to 100 (best possible scar); the higher the score, the better the scarring.

    Day 8

  • Wound Evaluation Scale (WES)

    WES is a 6-item scale. Items 1-5 are scored 0 (yes) or 1 (no), and item 6 is scored 0 (poor) or 1 (acceptable). The total score range is 0-6; the higher the score, the more optimal the wound healing.

    Day 8

Study Arms (2)

Antimicrobial Barrier Dressing

ACTIVE COMPARATOR

postoperative wound dressing with either anti-microbial dressing placed in the operating room from surgery to postoperative day 7

Combination Product: Antimicrobial Barrier Dressing

Closed-incision Negative Pressure Therapy

ACTIVE COMPARATOR

portable NPWT device placed in the operating room from surgery to postoperative day 7

Device: Negative Pressure Wound Therapy (NPWT)

Interventions

Ionic Silver is a soft, nonwoven pad or ribbon that features the gelling benefits of Hydrofiber technology plus antimicrobial ionic silver.

Also known as: AQUACEL Ag Hydrofiber Dressing
Antimicrobial Barrier Dressing

PICO provides suction known as negative Pressure wound Therapy (NPWT) which draws out excess fluid from a wound and protects the injured area from getting dirty to ultimately help promote healing. PICO consists of an nPwT pump connected to an absorbent gentle adhesive dressing

Also known as: PICO
Closed-incision Negative Pressure Therapy

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Those identified at pre-operative testing to have an elevated BMI (\> 35)

You may not qualify if:

  • Active infection
  • previous scar or wound healing complication
  • post traumatic degenerative joint disease (DJD) with hardware
  • revision surgery
  • inflammatory arthritis
  • anticoagulation outside of the standard of care.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

New York University School of Medicine

New York, New York, 10016, United States

Location

MeSH Terms

Conditions

Osteoarthritis

Interventions

Negative-Pressure Wound Therapy

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

DrainageTherapeuticsSurgical Procedures, OperativeWound Closure Techniques

Results Point of Contact

Title
Ran Schwarzkopf MD MSc
Organization
NYU Langone Health

Study Officials

  • Ran Schwarzkopf, MD

    NYU Langone Health

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 14, 2017

First Posted

November 17, 2017

Study Start

November 13, 2017

Primary Completion

April 1, 2021

Study Completion

June 1, 2021

Last Updated

April 22, 2022

Results First Posted

April 22, 2022

Record last verified: 2022-03

Locations